<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35807552</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>13</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>05</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Conversion of the Native N-Terminal Domain of TDP-43 into a Monomeric Alternative Fold with Lower Aggregation Propensity.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4309</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules27134309</ELocationID><Abstract><AbstractText>TAR DNA-binding protein 43 (TDP-43) forms intraneuronal cytoplasmic inclusions associated with amyotrophic lateral sclerosis and ubiquitin-positive frontotemporal lobar degeneration. Its N-terminal domain (NTD) can dimerise/oligomerise with the head-to-tail arrangement, which is essential for function but also favours liquid-liquid phase separation and inclusion formation of full-length TDP-43. Using various biophysical approaches, we identified an alternative conformational state of NTD in the presence of Sulfobetaine 3-10 (SB3-10), with higher content of &#x3b1;-helical structure and tryptophan solvent exposure. NMR shows a highly mobile structure, with partially folded regions and &#x3b2;-sheet content decrease, with a concomitant increase of &#x3b1;-helical structure. It is monomeric and reverts to native oligomeric NTD upon SB3-10 dilution. The equilibrium GdnHCl-induced denaturation shows a cooperative folding and a somewhat lower conformational stability. When the aggregation processes were compared with and without pre-incubation with SB3-10, but at the identical final SB3-10 concentration, a slower aggregation was found in the former case, despite the reversible attainment of the native conformation in both cases. This was attributed to protein monomerization and oligomeric seeds disruption by the conditions promoting the alternative conformation. Overall, the results show a high plasticity of TDP-43 NTD and identify strategies to monomerise TDP-43 NTD for methodological and biomedical applications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moretti</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marzi</LastName><ForeName>Isabella</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantarutti</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3435-9807</Identifier><AffiliationInfo><Affiliation>Department of Medical Area, University of Udine, 33100 Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vivoli Vega</LastName><ForeName>Mirella</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Biochemistry, University of Bristol, Bristol BS8 1TD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandaliti</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Medical Area, University of Udine, 33100 Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mimmi</LastName><ForeName>Maria Chiara</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bemporad</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-0643-6249</Identifier><AffiliationInfo><Affiliation>Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corazza</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2272-1928</Identifier><AffiliationInfo><Affiliation>Department of Medical Area, University of Udine, 33100 Udine, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INBB, Viale Medaglie d'Oro 305, 00136 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiti</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-1330-1289</Identifier><AffiliationInfo><Affiliation>Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>project TDP-43-STRUCT</GrantID><Agency>Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica</Agency><Country/></Grant><Grant><GrantID>Projects TDP43SLA</GrantID><Agency>Ente Cassa di Risparmio di Firenze</Agency><Country/></Grant><Grant><GrantID>Fondi Ateneo to F.C, and F.B.</GrantID><Agency>University of Florence</Agency><Country/></Grant><Grant><GrantID>Dipartimenti di Eccellenza 2018-2022 grant</GrantID><Agency>University of Pavia</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D066329">Protein Aggregates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="Y">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019281" MajorTopicYN="N">Dimerization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="Y">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066329" MajorTopicYN="N">Protein Aggregates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072757" MajorTopicYN="N">Protein Conformation, beta-Strand</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072417" MajorTopicYN="N">Protein Domains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">micelle</Keyword><Keyword MajorTopicYN="N">native-like</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">oligomerisation</Keyword><Keyword MajorTopicYN="N">self-assembly</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>9</Day><Hour>1</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35807552</ArticleId><ArticleId IdType="pmc">PMC9268139</ArticleId><ArticleId IdType="doi">10.3390/molecules27134309</ArticleId><ArticleId IdType="pii">molecules27134309</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Neumannn M., Bigio E.H., Cairns N.J., Alafuzoff I., Kril J., Kovacs G.G., Ghetti B., Halliday G., Holm I.E., et al. Nomenclature forneuropathologic subtypesof frontotemporal lobar degeneration: Consensus recommendations. Acta Neuropathol. 2009;117:15&#x2013;18. doi: 10.1007/s00401-008-0460-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0460-5</ArticleId><ArticleId IdType="pmc">PMC2710877</ArticleId><ArticleId IdType="pubmed">19015862</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W., Philips T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 2013;14:248&#x2013;264. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Cleveland D.W. The seeds of neurodegeneration: Prion-like spreading in ALS. Cell. 2011;147:498&#x2013;508. doi: 10.1016/j.cell.2011.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.10.011</ArticleId><ArticleId IdType="pmc">PMC3220614</ArticleId><ArticleId IdType="pubmed">22036560</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J.M., La Spada A.R. ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration. Neurology. 2009;73:805&#x2013;811. doi: 10.1212/WNL.0b013e3181b6bbbd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181b6bbbd</ArticleId><ArticleId IdType="pmc">PMC2739608</ArticleId><ArticleId IdType="pubmed">19738176</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T.J., Lee V.M.Y., Trojanowski J.Q. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol. Med. 2011;17:659&#x2013;667. doi: 10.1016/j.molmed.2011.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2011.06.004</ArticleId><ArticleId IdType="pmc">PMC3202652</ArticleId><ArticleId IdType="pubmed">21783422</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukavsky P.J., Daujotyte D., Tollervey J.R., Ule J., Stuani C., Buratti E., Baralle F.E., Damberger F.F., Allain F.H. Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43. Nat. Struct. Mol. Biol. 2013;20:1443&#x2013;1449. doi: 10.1038/nsmb.2698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2698</ArticleId><ArticleId IdType="pubmed">24240615</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo P.H., Chiang C.H., Wang Y.T., Doudeva L.G., Yuan H.S. The crystal structure of TDP-43 RRM1-DNA complex reveals the specific recognition for UG- and TG-rich nucleic acids. Nucleic Acids Res. 2014;42:4712&#x2013;4722. doi: 10.1093/nar/gkt1407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt1407</ArticleId><ArticleId IdType="pmc">PMC3985631</ArticleId><ArticleId IdType="pubmed">24464995</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin H., Lim L.Z., Wei Y., Song J. TDP-43N terminus encodes a novel ubiquitin-like fold and its unfolded form in equilibrium that can be shifted by binding to ssDNA. Proc. Natl. Acad. Sci. USA. 2014;111:18619&#x2013;18624. doi: 10.1073/pnas.1413994112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1413994112</ArticleId><ArticleId IdType="pmc">PMC4284588</ArticleId><ArticleId IdType="pubmed">25503365</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L.L., Zhao J., Yin X.F., He W.T., Yang H., Che M.X., Hu H.Y. Two mutations G335D and Q343R within the amyloidogenic core region of TDP-43 influence its aggregation and inclusion formation. Sci. Rep. 2016;6:23928. doi: 10.1038/srep23928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23928</ArticleId><ArticleId IdType="pmc">PMC4814915</ArticleId><ArticleId IdType="pubmed">27030292</ArticleId></ArticleIdList></Reference><Reference><Citation>Mompean M., Romano V., Pantoja-Uceda D., Stuani C., Baralle F.E., Buratti E., Laurents D.V. The TDP-43 N-terminal domain structure at high resolution. FEBS J. 2006;283:1242&#x2013;1260. doi: 10.1111/febs.13651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.13651</ArticleId><ArticleId IdType="pubmed">26756435</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiina Y., Arima K., Tabunoki H., Satoh J. TDP-43 dimerizes in human cells in culture. Cell. Mol. Neurobiol. 2010;30:641&#x2013;652. doi: 10.1007/s10571-009-9489-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-009-9489-9</ArticleId><ArticleId IdType="pubmed">20043239</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.K., Wu T.H., Wu C.Y., Chiang M.H., Toh E.K., Hsu Y.C., Lin K.F., Liao Y.H., Huang T.H., Huang J.J. The N-terminus of TDP-43 promotes its oligomerization and enhances DNA binding affinity. Biochem. Biophys. Res. Commun. 2012;425:219&#x2013;224. doi: 10.1016/j.bbrc.2012.07.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2012.07.071</ArticleId><ArticleId IdType="pubmed">22835933</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.J., Caulfield T., Xu Y.F., Gendron T.F., Hubbard J., Stetler C., Sasaguri H., Whitelaw E.C., Cai S., Lee W.C., et al. The dual functions of the extreme N-terminus of TDP-43 in regulating its biological activity and inclusion formation. Hum. Mol. Genet. 2013;22:3112&#x2013;3122. doi: 10.1093/hmg/ddt166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt166</ArticleId><ArticleId IdType="pmc">PMC3699067</ArticleId><ArticleId IdType="pubmed">23575225</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.T., Kuo P.H., Chiang C.H., Liang J.R., Chen Y.R., Wang S., Shen J.C., Yuan H.S. The truncated C-terminal RNA recognition motif of TDP-43 protein plays a key role in forming proteinaceous aggregates. J. Biol. Chem. 2013;288:9049&#x2013;9057. doi: 10.1074/jbc.M112.438564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.438564</ArticleId><ArticleId IdType="pmc">PMC3610977</ArticleId><ArticleId IdType="pubmed">23372158</ArticleId></ArticleIdList></Reference><Reference><Citation>Mompean M., Romano V., Pantoja-Uceda D., Stuani C., Baralle F.E., Buratti E., Laurents D.V. Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions. J. Biol. Chem. 2017;292:11992&#x2013;12006. doi: 10.1074/jbc.M117.775965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.775965</ArticleId><ArticleId IdType="pmc">PMC5512090</ArticleId><ArticleId IdType="pubmed">28566288</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L.L., Xue W., Hong J.Y., Zhang J.T., Li M.J., Yu S.N., He J.H., Hu H.Y. The N-terminal dimerization is required for TDP-43 splicing activity. Sci. Rep. 2017;7:6196. doi: 10.1038/s41598-017-06263-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-06263-3</ArticleId><ArticleId IdType="pmc">PMC5522446</ArticleId><ArticleId IdType="pubmed">28733604</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz T., Hock E.M., Ernst P., Foglieni C., Jambeau M., Gilhespy L.A.B., Laferriere F., Maniecka Z., Pl&#xfc;ckthun A., Mittl P., et al. Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nat. Commun. 2017;8:45. doi: 10.1038/s41467-017-00062-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00062-0</ArticleId><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A., Conicella A.E., Schmidt H.B., Martin E.W., Rhoads S.N., Reeb A.N., Nourse A., Ramirez Montero D., Ryan V.H., Rohatgi R., et al. A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing. EMBO J. 2018;37:e97452. doi: 10.15252/embj.201797452.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797452</ArticleId><ArticleId IdType="pmc">PMC5830921</ArticleId><ArticleId IdType="pubmed">29438978</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter G.C., Hsiung C.H., Simpson L., Yang H., Zhang X. N-terminal Domain of TDP43 Enhances Liquid-Liquid Phase Separation of Globular Proteins. J. Mol. Biol. 2013;433:166948. doi: 10.1016/j.jmb.2021.166948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2021.166948</ArticleId><ArticleId IdType="pmc">PMC8094807</ArticleId><ArticleId IdType="pubmed">33744316</ArticleId></ArticleIdList></Reference><Reference><Citation>Rengifo-Gonzalez J.C., El Hage K., Cl&#xe9;ment M.J., Steiner E., Joshi V., Craveur P., Durand D., Pastr&#xe9; D., Bouhss A. The cooperative binding of TDP-43 to GU-rich RNA repeats antagonizes TDP-43 aggregation. eLife. 2021;10:e67605. doi: 10.7554/eLife.67605.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.67605</ArticleId><ArticleId IdType="pmc">PMC8523171</ArticleId><ArticleId IdType="pubmed">34490845</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaguri H., Chew J., Xu Y.F., Gendron T.F., Garrett A., Lee C.W., Jansen-West K., Bauer P.O., Perkerson E.A., Tong J., et al. The extreme N-terminus of TDP-43 mediates the cytoplasmic aggregation of TDP-43 and associated toxicity in vivo. Brain Res. 2016;1647:57&#x2013;64. doi: 10.1016/j.brainres.2016.04.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.04.069</ArticleId><ArticleId IdType="pmc">PMC5003772</ArticleId><ArticleId IdType="pubmed">27155453</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivoli-Vega M., Guri P., Chiti F., Bemporad F. Insight into the Folding and Dimerization Mechanisms of the N-Terminal Domain from Human TDP-43. Int. J. Mol. Sci. 2020;21:6259. doi: 10.3390/ijms21176259.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21176259</ArticleId><ArticleId IdType="pmc">PMC7504384</ArticleId><ArticleId IdType="pubmed">32872449</ArticleId></ArticleIdList></Reference><Reference><Citation>Micsonai A., Wien F., Kernya L., Lee Y.H., Goto Y., R&#xe9;fr&#xe9;giers M., Kardos J. Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy. Proc. Natl. Acad. Sci. USA. 2015;112:3095&#x2013;3103. doi: 10.1073/pnas.1500851112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1500851112</ArticleId><ArticleId IdType="pmc">PMC4475991</ArticleId><ArticleId IdType="pubmed">26038575</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y., Delaglio F., Cornilescu G., Bax A. TALOS+: A Hybrid Method for Predicting Protein Backbone Torsion Angles from NMR Chemical Shifts. J. Biomol. NMR. 2009;44:213&#x2013;223. doi: 10.1007/s10858-009-9333-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10858-009-9333-z</ArticleId><ArticleId IdType="pmc">PMC2726990</ArticleId><ArticleId IdType="pubmed">19548092</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart D.S., Sykes B.D. The 13C Chemical-Shift Index: A Simple Method for the Identification of Protein Secondary Structure Using 13C Chemical-Shift Data. J. Biomol. NMR. 1994;4:171&#x2013;180. doi: 10.1007/BF00175245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00175245</ArticleId><ArticleId IdType="pubmed">8019132</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh J.A., Singh V.K., Jia Z., Forman-Kay J.D. Sensitivity of secondary structure propensities to sequence differences between alpha- and gamma-synuclein: Implications for fibrillation. Protein Sci. 2006;15:2795&#x2013;2804. doi: 10.1110/ps.062465306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1110/ps.062465306</ArticleId><ArticleId IdType="pmc">PMC2242444</ArticleId><ArticleId IdType="pubmed">17088319</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter N.J., Williamson M.P. Temperature Dependence of 1H Chemical Shifts in Proteins. J. Biomol. NMR. 1997;9:359&#x2013;369. doi: 10.1023/A:1018334207887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1018334207887</ArticleId><ArticleId IdType="pubmed">9255942</ArticleId></ArticleIdList></Reference><Reference><Citation>Kay L.E., Torchia D.A., Bax A. Backbone Dynamics of Proteins as Studied by Nitrogen-15 Inverse Detected Heteronuclear NMR Spectroscopy: Application to Staphylococcal Nuclease. Biochemistry. 1989;28:8972&#x2013;8979. doi: 10.1021/bi00449a003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00449a003</ArticleId><ArticleId IdType="pubmed">2690953</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro M.M., Bolen D.W. Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants. Biochemistry. 1988;27:8063&#x2013;8068. doi: 10.1021/bi00421a014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00421a014</ArticleId><ArticleId IdType="pubmed">3233195</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Lim L., Dang M., Song J. A novel mechanism for ATP to enhance the functional oligomerization of TDP-43 by specific binding. Biochem. Biophys. Res. Commun. 2019;514:809&#x2013;814. doi: 10.1016/j.bbrc.2019.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2019.05.006</ArticleId><ArticleId IdType="pubmed">31079926</ArticleId></ArticleIdList></Reference><Reference><Citation>LeVine H., 3rd Thioflavine T interaction with synthetic Alzheimer&#x2019;s disease beta-amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci. 1993;2:404&#x2013;410. doi: 10.1002/pro.5560020312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.5560020312</ArticleId><ArticleId IdType="pmc">PMC2142377</ArticleId><ArticleId IdType="pubmed">8453378</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue C., Lin T.Y., Chang D., Guo Z. Thioflavin T as an amyloid dye: Fibril quantification, optimal concentration and effect on aggregation. R. Soc. Open Sci. 2017;4:160696. doi: 10.1098/rsos.160696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsos.160696</ArticleId><ArticleId IdType="pmc">PMC5319338</ArticleId><ArticleId IdType="pubmed">28280572</ArticleId></ArticleIdList></Reference><Reference><Citation>Canet D., Last A.M., Tito P., Sunde M., Spencer A., Archer D.B., Redfield C., Robinson C.V., Dobson C.M. Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme. Nat. Struct. Biol. 2002;9:308&#x2013;315. doi: 10.1038/nsb768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsb768</ArticleId><ArticleId IdType="pubmed">11887182</ArticleId></ArticleIdList></Reference><Reference><Citation>Soldi G., Bemporad F., Torrassa S., Relini A., Ramazzotti M., Taddei N., Chiti F. Amyloid formation of a protein in the absence of initial unfolding and destabilization of the native state. Biophys. J. 2005;89:4234&#x2013;4244. doi: 10.1529/biophysj.105.067538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1529/biophysj.105.067538</ArticleId><ArticleId IdType="pmc">PMC1366988</ArticleId><ArticleId IdType="pubmed">16169977</ArticleId></ArticleIdList></Reference><Reference><Citation>Plakoutsi G., Bemporad F., Calamai M., Taddei N., Dobson C.M., Chiti F. Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates. J. Mol. Biol. 2005;351:910&#x2013;922. doi: 10.1016/j.jmb.2005.06.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2005.06.043</ArticleId><ArticleId IdType="pubmed">16024042</ArticleId></ArticleIdList></Reference><Reference><Citation>Eakin C.M., Berman A.J., Miranker A.D. A native to amyloidogenic transition regulated by a backbone trigger. Nat. Struct. Mol. Biol. 2006;13:202&#x2013;208. doi: 10.1038/nsmb1068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb1068</ArticleId><ArticleId IdType="pubmed">16491088</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Pardo J., Gra&#xf1;a-Montes R., Fernandez-Mendez M., Ruyra A., Roher N., Aviles F.X., Lorenzo J., Ventura S. Amyloid formation by human carboxypeptidase D transthyretin-like domain under physiological conditions. J. Biol. Chem. 2014;289:33783&#x2013;33796. doi: 10.1074/jbc.M114.594804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.594804</ArticleId><ArticleId IdType="pmc">PMC4256313</ArticleId><ArticleId IdType="pubmed">25294878</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart D.S., Bigam C.G., Yao J., Abildgaard F., Dyson H.J., Oldfield E., Markley J.L., Sykes B.D. 1H, 13C and 15N Chemical Shift Referencing in Biomolecular NMR. J. Biomol. NMR. 1995;6:135&#x2013;140. doi: 10.1007/BF00211777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00211777</ArticleId><ArticleId IdType="pubmed">8589602</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W., Tonelli M., Markley J.L. NMRFAM-SPARKY: Enhanced Software for Biomolecular NMR Spectroscopy. Bioinformatics. 2015;31:1325&#x2013;1327. doi: 10.1093/bioinformatics/btu830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu830</ArticleId><ArticleId IdType="pmc">PMC4393527</ArticleId><ArticleId IdType="pubmed">25505092</ArticleId></ArticleIdList></Reference><Reference><Citation>Uversky V.N. Size-exclusion chromatography in structural analysis of intrinsically disordered proteins. Methods Mol. Biol. 2012;896:179&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">22821524</ArticleId></ArticleIdList></Reference><Reference><Citation>Picotti P., De Franceschi G., Frare E., Spolaore B., Zambonin M., Chiti F., de Laureto P.P., Fontana A. Amyloid fibril formation and disaggregation of fragment 1-29 of apomyoglobin: Insights into the effect of pH on protein fibrillogenesis. J. Mol. Biol. 2007;367:1237&#x2013;1245. doi: 10.1016/j.jmb.2007.01.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2007.01.072</ArticleId><ArticleId IdType="pubmed">17320902</ArticleId></ArticleIdList></Reference><Reference><Citation>Motamedi-Shad N., Monsellier E., Chiti F. Amyloid formation by the model protein muscle acylphosphatase is accelerated by heparin and heparan sulphate through a scaffolding-based mechanism. J. Biochem. 2009;146:805&#x2013;814. doi: 10.1093/jb/mvp128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jb/mvp128</ArticleId><ArticleId IdType="pubmed">19675100</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>